Physician profile
Maher Awar
NPI 1124052154
$4,806.47
in general payments reported to CMS, 2019-2025
23 companies · $873 in 2025
The $873 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $212 · 2021: $200 · 2022: $909 · 2023: $1,696 · 2024: $649 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,408 · Travel and Lodging: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,407.86 |
| Travel and Lodging | $809.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $1,311.01 | 2022-2025 | Endocross Device, Torus Stent Graft System, Afx2 Bifurcated Endograft System |
| Medtronic, INC. | $837.85 | 2021-2025 | Micra, Venaseal, Protege Rx |
| Boston Scientific Corporation | $825.71 | 2022-2024 | Watchman Flx, Watchman Access System, Watchman |
| Medtronic Vascular, INC. | $401.73 | 2019-2020 | |
| Edwards Lifesciences Corporation | $305.35 | 2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $235.51 | 2022-2025 | Repatha |
| Silk Road Medical, INC. | $220.23 | 2021-2022 | |
| Abiomed | $105.11 | 2021-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $93.45 | 2019-2024 | |
| Baxter Healthcare | $66.58 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $52.33 | 2022-2023 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals Lp | $48.40 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.21 | 2022-2023 | Jardiance |
| Abbott Laboratories | $42.67 | 2024 | Diamondback Peripheral, Perclose Prostyle |
| E.R. Squibb & Sons, L.L.C. | $41.28 | 2022-2024 | Eliquis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $40.95 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.70 | 2022 | |
| Alnylam Pharmaceuticals INC. | $25.43 | 2022 | |
| Philips North America LLC | $21.90 | 2024 | (Ck4) Mcot |
| Cardiovascular Systems INC. | $17.93 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.82 | 2022 | |
| Preventice Services, LLC | $15.01 | 2021 | |
| Terumo Medical Corporation | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maher Awar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.